Pegademase Bovine Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of pegademase bovine during breastfeeding. Because it is a large protein molecule with a molecular weight of 113,000 Da, the amount in milk is likely to be very low and absorption is unlikely because it is probably partially destroyed in the infant's gastrointestinal tract and poorly absorbed orally. Polyethylene glycol is not excreted into breastmilk.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
1.
Clowse M, Förger F, Hwang C, et al. Minimal to no transfer of certolizumab pegol into breast milk: Results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis 2017;76:1890-6. [PMC free article: PMC5705850] [PubMed: 28814432]
Substance Identification
Substance Name
Pegademase Bovine
CAS Registry Number
130167-68-9
Drug Class
Breast Feeding
Lactation
Milk, Human
Enzymes
Enzyme Replacement Therapy
Adenosine Deaminase
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
